methazolamide has been researched along with Cognition Disorders in 1 studies
Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, M | 1 |
| Wang, W | 1 |
| Mai, H | 1 |
| Zhang, X | 1 |
| Wang, J | 1 |
| Gao, Y | 1 |
| Wang, Y | 1 |
| Deng, G | 1 |
| Gao, L | 1 |
| Zhou, S | 1 |
| Chen, Q | 1 |
| Wang, X | 1 |
1 other study available for methazolamide and Cognition Disorders
| Article | Year |
|---|---|
Methazolamide improves neurological behavior by inhibition of neuron apoptosis in subarachnoid hemorrhage mice.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Brain Edema; Caspase 3; Cerebral Cortex; Cognition Disorder | 2016 |